H
Hospital La Arruzafa | Cordoba, Spain
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
GT005
VRDN-001
Zimura
Teprotumumab
VRDN 001
Ripasudil
VRDN-003
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 14 total trials
This is a clinical trial assessing the safety and tolerability of an investigational drug, VRDN-003, in participants with Thyroid Eye Disease (TED).
Active, not recruiting
Thyroid Eye Disease (TED)
Drug: VRDN-003
Drug: Placebo
A study to assess the safety and efficacy of K-321 in participants with FECD after descemetorhexis.
Active, not recruiting
Fuchs Endothelial Corneal Dystrophy
Drug: Ripasudil
Drug: Placebo
A phase IIa, open label, non controlled clinical trial to assess the feasibility and safety of allogeneic adipose-derived mesenchymal stem cells (ASC...
Active, not recruiting
Pemphigoid
Lyell Syndrome
Drug: Double Dose
Drug: Single Dose
Trial sponsors
V
A
G
I
N
A
I
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems